AARTIPHARM.BOAARTIPHARM.BOBSE
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank100
3Y CAGR+13.8%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
+13.8%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1.5x
Solid growth
Streak
2 yr
Consecutive growthElevated
PeriodValueYoY Change
20253.23+44.2%
20242.24+74.3%
20231.29-41.4%
20222.19-
20210.00-
20200.00-